European Obesity Academy Assmannshausen 2016 Statistics; power calculation and randomization Johan Bring Statisticon AB.

Slides:



Advertisements
Similar presentations
Randomized Controlled Trial
Advertisements

Sample size estimation
Critical Appraisal: Epidemiology 101 POS Lecture Series April 28, 2004.
Basic Design Consideration. Previous Lecture Definition of a clinical trial The drug development process How different aspects of the effects of a drug.
Estimation of Sample Size
ODAC May 3, Subgroup Analyses in Clinical Trials Stephen L George, PhD Department of Biostatistics and Bioinformatics Duke University Medical Center.
Statistical Significance What is Statistical Significance? What is Statistical Significance? How Do We Know Whether a Result is Statistically Significant?
HYPOTHESIS TESTING Four Steps Statistical Significance Outcomes Sampling Distributions.
1 A Bayesian Non-Inferiority Approach to Evaluation of Bridging Studies Chin-Fu Hsiao, Jen-Pei Liu Division of Biostatistics and Bioinformatics National.
Evaluating Hypotheses Chapter 9. Descriptive vs. Inferential Statistics n Descriptive l quantitative descriptions of characteristics.
Journal Club Alcohol and Health: Current Evidence July-August 2006.
Chapter 11: Sequential Clinical Trials Descriptive Exploratory Experimental Describe Find Cause Populations Relationships and Effect Sequential Clinical.
Statistical Significance What is Statistical Significance? How Do We Know Whether a Result is Statistically Significant? How Do We Know Whether a Result.
Evaluating Hypotheses Chapter 9 Homework: 1-9. Descriptive vs. Inferential Statistics n Descriptive l quantitative descriptions of characteristics ~
Clinical Trials Hanyan Yang
C82MCP Diploma Statistics School of Psychology University of Nottingham 1 Overview of Lecture Independent and Dependent Variables Between and Within Designs.
BS704 Class 7 Hypothesis Testing Procedures
Statistical Comparison of Two Learning Algorithms Presented by: Payam Refaeilzadeh.
Statistics 03 Hypothesis Testing ( 假设检验 ). When we have two sets of data and we want to know whether there is any statistically significant difference.
Sample Size Determination Ziad Taib March 7, 2014.
Power and Non-Inferiority Richard L. Amdur, Ph.D. Chief, Biostatistics & Data Management Core, DC VAMC Assistant Professor, Depts. of Psychiatry & Surgery.
Accredited Member of the Association of Clinical Research Professionals, USA Tips on clinical trials Maha Al-Farhan B.Sc, M.Phil., M.B.A., D.I.C.
Chapter 4 Hypothesis Testing, Power, and Control: A Review of the Basics.
1 © Lecture note 3 Hypothesis Testing MAKE HYPOTHESIS ©
HYPOTHESIS TESTING Dr. Aidah Abu Elsoud Alkaissi
Dr Mohammad Hossein Fallahzade Determining the Size of a Sample In the name of God.
CHP400: Community Health Program - lI Research Methodology. Data analysis Hypothesis testing Statistical Inference test t-test and 22 Test of Significance.
Gil Harari Statistical considerations in clinical trials
NY, 14 December 2007 Emmanuel Lesaffre Biostatistical Centre, K.U.Leuven, Leuven, Belgium Dept of Biostatistics, Erasmus MC, Rotterdam, the Netherlands.
Sample size determination Nick Barrowman, PhD Senior Statistician Clinical Research Unit, CHEO Research Institute March 29, 2010.
Statistical Power and Sample Size Calculations Drug Development Statistics & Data Management July 2014 Cathryn Lewis Professor of Genetic Epidemiology.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases Division, University of Louisville Chief, Infectious Diseases Section, Veterans.
Challenges of Non-Inferiority Trial Designs R. Sridhara, Ph.D.
Scientific Method for a controlled experiment. Observation Previous data Previous results Previous conclusions.
Inference and Inferential Statistics Methods of Educational Research EDU 660.
Chapter 12 A Primer for Inferential Statistics What Does Statistically Significant Mean? It’s the probability that an observed difference or association.
1 OTC-TFM Monograph: Statistical Issues of Study Design and Analyses Thamban Valappil, Ph.D. Mathematical Statistician OPSS/OB/DBIII Nonprescription Drugs.
How to find a paper Looking for a known paper: –Field search: title, author, journal, institution, textwords, year (each has field tags) Find a paper to.
1 Statistics in Drug Development Mark Rothmann, Ph. D.* Division of Biometrics I Food and Drug Administration * The views expressed here are those of the.
What is a non-inferiority trial, and what particular challenges do such trials present? Andrew Nunn MRC Clinical Trials Unit 20th February 2012.
Inferential Statistics Body of statistical computations relevant to making inferences from findings based on sample observations to some larger population.
GNRS 713 Week 3 T-tests. StatisticsDescriptiveInferentialCorrelational Relationships GeneralizingOrganizing, summarising & describing data Significance.
통계적 추론 (Statistical Inference) 삼성생명과학연구소 통계지원팀 김선우 1.
Introduction to sample size and power calculations Afshin Ostovar Bushehr University of Medical Sciences.
How to read a paper D. Singh-Ranger. Academic viva 2 papers 1 hour to read both Viva on both papers Summary-what is the paper about.
Statistical Inference for the Mean Objectives: (Chapter 9, DeCoursey) -To understand the terms: Null Hypothesis, Rejection Region, and Type I and II errors.
Federal Institute for Drugs and Medical Devices The BfArM is a Federal Institute within the portfolio of the Federal Ministry of Health (BMG) The use of.
EBM Conference (Day 2). Funding Bias “He who pays, Calls the Tune” Some Facts (& Myths) Is industry research more likely to be published No Is industry.
Critical Reading. Critical Appraisal Definition: assessment of methodological quality If you are deciding whether a paper is worth reading – do so on.
Joel Singer, Programme Head, Methodology and Statistics, CIHR Canadian HIV Trials Network.
Compliance Original Study Design Randomised Surgical care Medical care.
THE ROLE OF SUBGROUPS IN CLINICAL TRIALS Ralph B. D’Agostino, Sr., PhD Boston University September 13, 2005.
European Patients’ Academy on Therapeutic Innovation The Purpose and Fundamentals of Statistics in Clinical Trials.
Course: Research in Biomedicine and Health III Seminar 5: Critical assessment of evidence.
The Idea of the Statistical Test. A statistical test evaluates the "fit" of a hypothesis to a sample.
BHS Methods in Behavioral Sciences I May 9, 2003 Chapter 6 and 7 (Ray) Control: The Keystone of the Experimental Method.
بسم الله الرحمن الرحیم.
European Patients’ Academy on Therapeutic Innovation Clinical Trial Designs.
C HAPTER 2  Hypothesis Testing -Test for one means - Test for two means -Test for one and two proportions.
Statistical Inference for the Mean Objectives: (Chapter 8&9, DeCoursey) -To understand the terms variance and standard error of a sample mean, Null Hypothesis,
How to read a paper D. Singh-Ranger.
Critical Reading of Clinical Study Results
MATH 2311 Section 8.2.
بسم الله الرحمن الرحیم.
One-Way Analysis of Variance: Comparing Several Means
Statistical significance using p-value
Statistical Power.
Medical Statistics Exam Technique and Coaching, Part 2 Richard Kay Statistical Consultant RK Statistics Ltd 22/09/2019.
Hypothesis Testing for the mean. The general procedure.
Presentation transcript:

European Obesity Academy Assmannshausen 2016 Statistics; power calculation and randomization Johan Bring Statisticon AB

Study process Planing Data collection Analysis Interpre- tation

ICH E9 – statistical principles ”This guidance is written primarily to attempt to harmonize the principles of statistical methodology applied to clinical trials for marketing applications submitted in Europe, Japan and the United States.” (p. 3)

Study objective Superiority A>B Equivalence A=B Non-inferiority A not worse than B

Overall Study Design One group Parallell groups Cross over Choice of control groups Placebo Active control Dose comparisons

Selection of study population Inclusion and exclusion criteria Methods of assigning patients to treatment groups Randomization Blinding

Primary efficacy variable(s) 1) ”The primary variable should be the variable capable of providing the most clinically relevant and convincing evidence directly related to the primary objective.” 2) ”There should generally be only one primary variable.” 3) ”The selection of the primary variable should reflect the accepted norms and standards in the field of research.” 4) ”The use of a reliable and validated variable with which experience has been gained is recommended.”

Cathegorised Variables It’s common to dichotomize continues response variables into responders/non-responders, e.g. -Reduction in BMI: more than 5%=1, less than 5%=0 -Obstructive sleep apnea: AHI>15 -Diastolic bloodpreasure, below 90mmHg=1, above 90mmHg=0 -Reduction in VAS-score, more than 30%=1, less than 30%=0 -Hb above 120=1, below 120=0.

Determination of sample size – hypothesis testing ’Accept’ H0 Reject H0 H0 true CorrectTyp-I error α H0 false Typ-II error β Correct H0: A = B H1: A ≠ B

How large risks should we take?

What does it mean that H1 is true?

An example Two surgical procedures (1 and 2) 1 is the old procedure and 2 is the new procedure We study the proportion of succesful operations. The old procedure has a succesrate of 0.20 (20%)

n1=100 n2=100

p1=0.20 p2=0.30

How determine the sample size Decide alfa (level of significance). Decide power. Decide smallest difference that is considered clinically relevant. (delta). (Note: that is not the same as the expected difference)

Studies with low power – are they unethical? Yes No

Subgroup analyses Significant effect for females Non-significant effect for females Significant effect for males Non-significant effect for males Probabilities for different outcomes